Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Non-Current Deferred Tax Liability (2017 - 2023)

Aclaris Therapeutics has reported Non-Current Deferred Tax Liability over the past 7 years, most recently at $367000.0 for Q3 2023.

  • Quarterly results put Non-Current Deferred Tax Liability at $367000.0 for Q3 2023, changed 0.0% from a year ago — trailing twelve months through Sep 2023 was $367000.0 (changed 0.0% YoY), and the annual figure for FY2022 was $367000.0, changed 0.0%.
  • Non-Current Deferred Tax Liability for Q3 2023 was $367000.0 at Aclaris Therapeutics, roughly flat from $367000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for ACRS hit a ceiling of $549000.0 in Q1 2019 and a floor of $367000.0 in Q4 2020.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $367000.0 (2020), compared with a mean of $434052.6.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: changed 0.0% in 2019 and later plummeted 33.15% in 2020.
  • Aclaris Therapeutics' Non-Current Deferred Tax Liability stood at $549000.0 in 2019, then plummeted by 33.15% to $367000.0 in 2020, then changed by 0.0% to $367000.0 in 2021, then changed by 0.0% to $367000.0 in 2022, then changed by 0.0% to $367000.0 in 2023.
  • The last three reported values for Non-Current Deferred Tax Liability were $367000.0 (Q3 2023), $367000.0 (Q2 2023), and $367000.0 (Q1 2023) per Business Quant data.